Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane and hypothermic lung inflation during cardiopulmonary bypass for lung protection in valve replacement surgery
ChiCTR-TRC-11001373Phase 4Completed
- Sponsor
- The 2nd Affiliated Hospital of Harbin Medical University
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sevoflurane and propofol in mitral valve disease and aortic valve disease (AVD) (4 arms), sponsored by The 2nd Affiliated Hospital of Harbin Medical University. Primary endpoints: oxygenation index, extravascular lung water index and 4 more. Started Mar 2011; status: completed.
02
Drugs
sevofluranepropofol
03
Conditions
mitral valve diseaseaortic valve disease (AVD)
Beyond the preview
Go deeper on ChiCTR-TRC-11001373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001373.